Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07686081 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis

Name: Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis — clinical trial record (NCT07686081)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorVanda Pharmaceuticals

Started2026-09

View on ClinicalTrials.gov ↗

Amendment history

2026-08-14

Study Status, Outcome Measures, Contacts/Locations v1

Recruitment opened

Secondary endpointsdetails revised at 1 of 4 entries

Study sitesdetails revised at 2 of 2 sites

2026-06-30

Original filing

Vanda Pharmaceuticals

23 trials monitored

See 3 trials at risk

Ulcerative Colitis

582 trials monitored

See 29 trials at risk

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of Ponesimod (VSP-128) in patients with moderately to severely active ulcerative colitis

Trial Details

NCT Number	NCT07686081
Lead Sponsor	Vanda Pharmaceuticals
Conditions	Ulcerative Colitis (UC)
Enrollment	150 participants
Start Date	2026-09
Primary Completion	2029-04 (estimated)
Study Completion	2029-08 (estimated)
Updated on ClinicalTrials.gov	2026-08-18